statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ecolab Life Sciences and Repligen Announce the Commercial Launch of DurA Cycle Affinity Resin for Large-Scale Biologic Manufacturing

Ecolab today announced that its Purolite resin business, together with Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the...

Should Weakness in Repligen Corporation's (NASDAQ:RGEN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

With its stock down 7.9% over the past week, it is easy to disregard Repligen (NASDAQ:RGEN). However, the company's...

Repligen Co. (NASDAQ:RGEN) Receives $196.70 Average Price Target from Analysts

Repligen Co. (NASDAQ:RGEN  Get Free Report) has been given a consensus rating of Moderate Buy by the nine brokerages that are currently covering the firm, Marketbeat.com reports...

Repligen Appoints Maggie A. Pax to Board of Directors

WALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax...

Zacks Research Brokers Lower Earnings Estimates for Repligen Co. (NASDAQ:RGEN)

Repligen Co. (NASDAQ:RGEN  Free Report)  Zacks Research dropped their Q1 2024 earnings per share (EPS) estimates for Repligen in a note issued to investors on Wednesday, March 13th...

Repligen Co. (NASDAQ:RGEN) to Post Q1 2024 Earnings of $0.29 Per Share, Zacks Research Forecasts

Repligen Co. (NASDAQ:RGEN  Free Report)  Research analysts at Zacks Research dropped their Q1 2024 earnings per share estimates for shares of Repligen in a research note issued to...

Repligen Co. (NASDAQ:RGEN) VP Sells $681,348.41 in Stock

Repligen Co. (NASDAQ:RGEN  Get Free Report) VP Ralf Kuriyel sold 3,517 shares of the firms stock in a transaction dated Monday, March 11th. The shares were sold at an average price of...

Comerica Bank Increases Position in Repligen Co. (NASDAQ:RGEN)

Comerica Bank grew its position in shares of Repligen Co. (NASDAQ:RGEN  Free Report) by 1,259.1% during the third quarter, according to its most recent Form 13F filing with the Securities...

Repligen Corp CEO Anthony Hunt Sells 16,707 Shares

Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Volume	1.12M
52-Wk High	$211.13
52-Wk Low	$110.45

RGEN Repligen Corp.

About

Feed

News

Sentiment

Earnings

Fundamentals